Exemplar toolkit

The Exemplar Programme captured best practice on the delivery of 18 commercial studies adopted to the NIHR Clinical Research Network Portfolio in the North West. The Programme led to a set of recommendations designed to help the clinical research community improve the set up and delivery of research studies in the NHS.

The Clinical Research Network, NHS and Life-sciences Industry have all received toolkits that outline what their recommendations are and how they can contribute to the improvement of the research environment.

The toolkit below is designed for, and developed in collaboration with, the Life-sciences Industry. The kit contains four tools that can be used to help improve study performance:

• the slide-set - a review of the Exemplar Programme and how you can use findings to improve the performance of your studies in the NHS
• the leaflet - an outline of the Exemplar Programme, its recommendations and future steps
• the letter - highlights the role the Life-science Industry can play in engaging more effectively with the NHS and Clinical Research Network and the impact this can have on the performance of studies. The letter is co-signed by Jonathan Sheffield, Chief Executive of the Clinical Research Network and Dr Allison Jeynes-Ellis, Medical & Innovation Director of the Association of the British Pharmaceutical Industry (ABPI) and was distributed through the ABPI, to Industry Medical Directors, in September 2011
• the escalation guide - outlines a recommended route for companies to escalate and resolve study issues
• the study start-up route map - developed independently of the Exemplar Programme, but included in this kit because it addresses one of the key Exemplar recommendations: who does what and when during the life cycle of a Portfolio study. This map will help you understand who is responsible for your study at the various stages of its development.

Download the toolkit